Asia Pharmaceuticals Enters Gastric Ulcer Market

Published: 2004-12-02 06:56:00

Updated: 2004-12-02 06:56:00

Asia Pharmaceuticals (Korean: A-Ju Pharm), via its strategic partnership with Japan’s Kotobuki Pharmaceuticals, enters the domestic gastric ulcer treatment market by launching Azuroxa Granule (Egualen Na 15mg).

Azuroxa Granule, developed by Kotobuki Pharmaceuticals, has Azuroxa, a new derivati...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK